Outlook on the Cell & Gene Therapy Clinical Trials Global Market to 2027 - by Phase, Application and Region - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 7, 2022--

The "Cell & Gene Therapy Clinical Trials Market Research Report - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Cell & Gene Therapy Clinical Trials Market size was estimated at USD 5,248.64 million in 2021, USD 5,914.70 million in 2022, and is projected to grow at a CAGR of 12.94% to reach USD 10,895.54 million by 2027.

Companies Mentioned

• Accell Clinical Research, LLC
• Atlant Clinical Ltd.
• Charles River Laboratories International, Inc.
• Eli Lilly and Company
• ICON Plc
• IQVIA Inc.
• Laboratory Corporation Of America Holdings
• Medpace Holdings, Inc.
• Novartis AG
• Novo Nordisk A/S
• Novotech Pty Limited
• Parexel International Corporation
• Pfizer Inc.
• Ppd, Inc.
• ProPharma Group Holdings, LLC
• SGS S.A.
• Syneos Health, Inc.
• Thermo Fisher Scientific Inc.
• Veristat, Llc
• Wuxi AppTec Inc.

Market Segmentation & Coverage:

This research report categorizes the Cell & Gene Therapy Clinical Trials to forecast the revenues and analyze the trends in each of the following sub-markets:

• Based on Phase, the market was studied across Phase I, Phase II, Phase III, and Phase IV.
• Based on Application, the market was studied across Cardiology, CNS, Dermatology, Endocrine, Metabolic, Genetic, Gastroenterology, Hematology, Immunology & Inflammation, Infectious Diseases, Musculoskeletal, Oncology, and Ophthalmology.
• Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell & Gene Therapy Clinical Trials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell & Gene Therapy Clinical Trials Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell & Gene Therapy Clinical Trials Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell & Gene Therapy Clinical Trials Market?

4. What is the competitive strategic window for opportunities in the Global Cell & Gene Therapy Clinical Trials Market?

5. What are the technology trends and regulatory frameworks in the Global Cell & Gene Therapy Clinical Trials Market?

6. What is the market share of the leading vendors in the Global Cell & Gene Therapy Clinical Trials Market?

7. What modes and strategic moves are considered suitable for entering the Global Cell & Gene Therapy Clinical Trials Market?

For more information about this report visit https://www.researchandmarkets.com/r/kgr5qe

View source version on businesswire.com:https://www.businesswire.com/news/home/20221107005808/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS OTHER HEALTH COVID-19 CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.